Good afternoon,
Hypothetically, might it be acceptable to develop an unbranded APS directed to HCP with an educational focus on an emerging therapeutic technology, given that i) the APS would have no mention of or linkage to any condition or therapeutic area, ii) the technology is not exclusively applied to one therapeutic area, and iii) such technology is already utilized in pharmaceuticals that have been approved in Canada?
Thank you.